DE69233399D1 - Menschliches cyclin e - Google Patents

Menschliches cyclin e

Info

Publication number
DE69233399D1
DE69233399D1 DE69233399T DE69233399T DE69233399D1 DE 69233399 D1 DE69233399 D1 DE 69233399D1 DE 69233399 T DE69233399 T DE 69233399T DE 69233399 T DE69233399 T DE 69233399T DE 69233399 D1 DE69233399 D1 DE 69233399D1
Authority
DE
Germany
Prior art keywords
human cyclin
cyclin
polypeptide
determining
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69233399T
Other languages
English (en)
Other versions
DE69233399T2 (de
Inventor
James M Roberts
Motoaki Ohtsubo
Andrew C Koff
Frederick Cross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fred Hutchinson Cancer Center
Original Assignee
Fred Hutchinson Cancer Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fred Hutchinson Cancer Research Center filed Critical Fred Hutchinson Cancer Research Center
Application granted granted Critical
Publication of DE69233399D1 publication Critical patent/DE69233399D1/de
Publication of DE69233399T2 publication Critical patent/DE69233399T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69233399T 1991-09-20 1992-09-16 Menschliches cyclin e Expired - Fee Related DE69233399T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76430991A 1991-09-20 1991-09-20
US764309 1991-09-20
PCT/US1992/007866 WO1993006123A1 (en) 1991-09-20 1992-09-16 Human cyclin e

Publications (2)

Publication Number Publication Date
DE69233399D1 true DE69233399D1 (de) 2004-09-16
DE69233399T2 DE69233399T2 (de) 2005-08-04

Family

ID=25070333

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69233399T Expired - Fee Related DE69233399T2 (de) 1991-09-20 1992-09-16 Menschliches cyclin e

Country Status (7)

Country Link
US (5) US5449755A (de)
EP (1) EP0604560B1 (de)
JP (2) JPH07502164A (de)
AT (1) ATE273386T1 (de)
CA (1) CA2119443C (de)
DE (1) DE69233399T2 (de)
WO (1) WO1993006123A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE273386T1 (de) * 1991-09-20 2004-08-15 Hutchinson Fred Cancer Res Menschliches cyclin e
US5596079A (en) * 1991-12-16 1997-01-21 Smith; James R. Mimetics of senescent cell derived inhibitors of DNA synthesis
US6372249B1 (en) 1991-12-16 2002-04-16 Baylor College Of Medicine Senscent cell-derived inhibitors of DNA synthesis
US5484727A (en) * 1992-10-14 1996-01-16 Trustees Of Dartmouth College Cloned gene encoding acylcoenzyme A: cholesterol acyltransferase (ACAT)
US5543291A (en) * 1993-01-29 1996-08-06 Dana Farber Cancer Institute Method of detecting carcinoma
US5443962A (en) * 1993-06-04 1995-08-22 Mitotix, Inc. Methods of identifying inhibitors of cdc25 phosphatase
US5625031A (en) * 1994-02-08 1997-04-29 Bristol-Myers Squibb Company Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
DE19539130C2 (de) * 1995-02-28 1999-05-12 Max Planck Gesellschaft Mittel zur Therapie von Tumoren und anderen Hyperplasien
AU7015396A (en) * 1995-09-07 1997-03-27 Health Research Incorporated Cyclin e variants and use thereof
US20030086927A1 (en) * 1995-11-01 2003-05-08 University Of Southern California Expression of cyclin G1 in tumors
GB9613418D0 (en) * 1996-06-26 1996-08-28 Crc Technology Ltd A cell-free system for initiation of DNA replication
JP2000515744A (ja) * 1996-07-24 2000-11-28 ファルマシア・アンド・アップジョン・カンパニー サイクリンｅの構築体および複合体
US6274312B1 (en) 1996-12-11 2001-08-14 Schering Corporation Intracellular regulatory molecules; related reagents
EP0983510B1 (de) * 1997-05-20 2004-03-03 Erasmus Universiteit Rotterdam Erkennung von tmorspezifische genprodukte
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
EA003527B1 (ru) * 1997-10-27 2003-06-26 Агурон Фармасьютикалз, Инк. Замещенные 4-аминотиазолы в качестве ингибиторов циклинзависимых киназ
US5973119A (en) 1998-06-05 1999-10-26 Amgen Inc. Cyclin E genes and proteins
US6624171B1 (en) * 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
US6492398B1 (en) 1999-03-04 2002-12-10 Smithkline Beechman Corporation Thiazoloindolinone compounds
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
AU2088100A (en) * 1999-06-23 2001-01-31 Angiogene Inc. Antisense oligonucleotide modulating cyclin e gene expression and therapeutic uses thereof
JP2003510049A (ja) * 1999-09-23 2003-03-18 ライジェル・ファーマシューティカルズ・インコーポレイテッド Ｔｒａｆ４関連細胞周期タンパク質、組成物および使用法
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
US6589725B1 (en) 1999-10-25 2003-07-08 Rigel Pharmaceuticals, Inc. Tankyrase H, compositions involved in the cell cycle and methods of use
US6887675B1 (en) 1999-10-25 2005-05-03 Rigel Pharmaceuticals, Inc. Tankyrase H, compositions involved in the cell cycle and methods of use
US20030149113A1 (en) * 2001-10-12 2003-08-07 Caplan Michael J. Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
US20030236300A1 (en) * 1999-10-27 2003-12-25 Yale University Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
AU784349C (en) 2000-01-12 2006-09-28 Yale University Nogo receptor-mediated blockade of axonal growth
WO2001059448A1 (fr) * 2000-02-10 2001-08-16 Chugai Seiyaku Kabushiki Kaisha Procede de criblage d'un agent antiandrogene
US6620818B1 (en) 2000-03-01 2003-09-16 Smithkline Beecham Corporation Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
CN1322733A (zh) * 2000-05-09 2001-11-21 上海博德基因开发有限公司 一种新的多肽——人npat蛋白11和编码这种多肽的多核苷酸
EP1685379A4 (de) * 2003-07-11 2007-07-11 Merck & Co Inc Verfahren zur identifizierung von zelloberflächen-rezeptorprotein-modulatoren
AU2004319946A1 (en) 2004-04-22 2005-12-01 3-Dimensional Pharmaceuticals, Inc. HDM2-inhibitor complexes and uses thereof
WO2007011702A2 (en) * 2005-07-15 2007-01-25 The University Of North Carolina At Chapel Hill Use of egfr inhibitors to prevent or treat obesity
US20170117214A1 (en) 2009-01-05 2017-04-27 Amkor Technology, Inc. Semiconductor device with through-mold via
CN116217722B (zh) * 2023-03-22 2023-09-15 广东省第二人民医院（广东省卫生应急医院） 一种抗CyclinE蛋白的纳米抗体及编码基因和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658204A1 (fr) * 1990-02-12 1991-08-16 Inst Nat Sante Rech Med Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv.
ATE273386T1 (de) * 1991-09-20 2004-08-15 Hutchinson Fred Cancer Res Menschliches cyclin e
US5543291A (en) * 1993-01-29 1996-08-06 Dana Farber Cancer Institute Method of detecting carcinoma

Also Published As

Publication number Publication date
EP0604560A4 (de) 1995-05-24
JP2004222728A (ja) 2004-08-12
EP0604560A1 (de) 1994-07-06
US5645999A (en) 1997-07-08
US5861259A (en) 1999-01-19
CA2119443C (en) 1999-11-02
JPH07502164A (ja) 1995-03-09
AU676137B2 (en) 1997-03-06
WO1993006123A1 (en) 1993-04-01
US5783661A (en) 1998-07-21
CA2119443A1 (en) 1993-04-01
DE69233399T2 (de) 2005-08-04
EP0604560B1 (de) 2004-08-11
AU2666392A (en) 1993-04-27
US5449755A (en) 1995-09-12
ATE273386T1 (de) 2004-08-15
US5807698A (en) 1998-09-15

Similar Documents

Publication Publication Date Title
DE69233399D1 (de) Menschliches cyclin e
DE68908439D1 (de) Quatenaere-ammonium-verbindungen zur verwendung in bleich-systemen.
GR3025596T3 (en) Compositions and methods for identifying biologically active molecules.
DE68924816D1 (de) Sitzanordnung zur Verwendung in Fahrzeugen.
NO873933D0 (no) Permeabilitetsstabilisering i underjordiske formasjoner inneholdende partikkelformig materiale.
DE69030959T2 (de) EEPROM mit Referenzzelle
DE69021282T2 (de) Prepolymere zur Verwendung in biomedizinischen Vorrichtungen.
IL60961A (en) Beta-galactosyl-umbelliferone-labeled protein or polypeptide conjugates and their use in immunoassay methods
DE68904358T2 (de) Prostaglandinanaloge zur verwendung in der medizin.
ES532985A0 (es) Procedimiento de preparar concentrados y nutrimentos proteinicos
DE69013129D1 (de) Vorrichtung zur Zellfärbung.
DE58903324D1 (de) Pflanzliche wirkstoffzubereitung zur verwendung in kosmetika.
DE3851007T2 (de) Zusammensetzung zur Verwendung in der Landwirtschaft.
DE3585049D1 (de) Monoklonale antikoerper.
NO860344L (no) Vevskultur og fremstilling i permeable geler.
FR2689904B1 (fr) Test de bronzage épidermique in vitro.
DE3682358D1 (de) Expressionsvektoren zur verwendung in e. coli.
IT8920661A0 (it) Coperchio scorrevole in materiale trasparente.
DE69006421D1 (de) Aussparung in Arbeitsplatten mit niedriger Spannungs-Konzentration.
DE3781745T2 (de) Antikoerper zur verwendung fuer die bestimmung von menschlichem glycoalbumin.
NO161078C (no) Testsett for bestemmelse av mikroorganismen streptococcusmutans i menneskesaliva.
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
ATA160189A (de) Zubereitungen zur verwendung in der bauindustrie
DE68906167T2 (de) Zusammensetzung zur erkennung von paradontalen krankheiten.
DE69110861D1 (de) Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee